Artificial Heart Market Size, Share, Trends, Growth Outlook

Artificial Heart Market is estimated to increase at a growth rate of 18.8% CAGR over the forecast period from 2024 to 2030.

The global Artificial Heart Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Ventricular Assist Device, Total Artificial Heart, Heart-Lung Machine, Others), By Power Source (Internal Battery, External Battery), By End-User (Hospitals and Clinics, Specialty Clinics).

An Introduction to Artificial Heart Market in 2024

The Artificial Heart Market in 2024 focuses on cardiac assist devices, artificial hearts, and implantable heart pumps used in cardiology and cardiovascular surgery for providing circulatory support, cardiac function enhancement, and heart failure management. These artificial heart technologies include left ventricular assist devices (LVADs), total artificial hearts (TAHs), and ventricular assist devices (VADs), offering mechanical pumping mechanisms, blood flow regulation, and cardiac output optimization for patients with end-stage heart failure or awaiting heart transplantation. With a focus on bridge-to-transplant therapy, destination therapy options, and long-term cardiac support, artificial hearts contribute to heart failure treatment, cardiac recovery, and quality of life improvement for heart failure patients.

Artificial Heart Market Competitive Landscape

The global Artificial Heart Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Artificial Heart Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Artificial Heart Industry include- Abbott Laboratories, Abiomed, Berlin Heart Inc, BiVACOR Inc, Calon Cardio-Technology Ltd, Carmat, CryoLife Inc, Jarvik Heart Inc, ReinHeart TAH GmbH, SynCardia Systems Llc.

Artificial Heart Market Trend: Integration of Remote Monitoring and Connectivity

In the Artificial Heart market, a significant trend is the integration of remote monitoring and connectivity features in artificial heart devices. With advancements in sensor technology and wireless communication, artificial heart manufacturers are incorporating remote monitoring capabilities that allow healthcare providers to track patient health metrics, device performance, and adherence to treatment remotely. This trend enables proactive management of patient care, early detection of device malfunctions or complications, and timely intervention, ultimately improving patient outcomes and reducing hospital readmissions.

Artificial Heart Market Driver: Growing Incidence of Heart Failure and Cardiovascular Diseases

A key driver for the Artificial Heart market is the growing incidence of heart failure and cardiovascular diseases worldwide. As the prevalence of heart failure rises due to factors such as aging populations, sedentary lifestyles, and obesity, there's an increasing need for advanced treatment options for end-stage heart failure patients who are ineligible for heart transplantation. Artificial hearts offer a life-saving solution for these patients by providing mechanical circulatory support and improving quality of life, driving market demand for innovative devices that offer durability, reliability, and compatibility with patient physiology.

Artificial Heart Market Opportunity: Miniaturization and Implantation Techniques

An opportunity exists in the miniaturization of artificial heart devices and the development of minimally invasive implantation techniques. By reducing device size, improving biocompatibility, and refining surgical approaches, there's potential to enhance patient outcomes, reduce surgical complications, and expand the eligible patient population for artificial heart therapy. Furthermore, advancements in implantation techniques such as percutaneous insertion or minimally invasive surgery can reduce surgical trauma, shorten recovery times, and improve patient acceptance of artificial heart implants. Collaboration among medical device manufacturers, cardiac surgeons, and regulatory agencies can drive innovation in miniaturization and implantation techniques, unlocking new opportunities for market growth in the Artificial Heart segment.

Market Share Analysis: Ventricular Assist Device (VAD)

Artificial Heart Market Segmentation

By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Artificial Heart Companies

Abbott Laboratories
Abiomed
Berlin Heart Inc
BiVACOR Inc
Calon Cardio-Technology Ltd
Carmat
CryoLife Inc
Jarvik Heart Inc
ReinHeart TAH GmbH
SynCardia Systems Llc
* List not Exhaustive

Reasons to Buy the Artificial Heart Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Artificial Heart Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Artificial Heart Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Artificial Heart Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Artificial Heart Market Size Outlook, $ Million, 2021 to 2030
3.2 Artificial Heart Market Outlook by Type, $ Million, 2021 to 2030
3.3 Artificial Heart Market Outlook by Product, $ Million, 2021 to 2030
3.4 Artificial Heart Market Outlook by Application, $ Million, 2021 to 2030
3.5 Artificial Heart Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Artificial Heart Industry
4.2 Key Market Trends in Artificial Heart Industry
4.3 Potential Opportunities in Artificial Heart Industry
4.4 Key Challenges in Artificial Heart Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Artificial Heart Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Artificial Heart Market Outlook by Segments
7.1 Artificial Heart Market Outlook by Segments, $ Million, 2021- 2030
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
8 North America Artificial Heart Market Analysis and Outlook To 2030
8.1 Introduction to North America Artificial Heart Markets in 2024
8.2 North America Artificial Heart Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Artificial Heart Market size Outlook by Segments, 2021-2030
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
9 Europe Artificial Heart Market Analysis and Outlook To 2030
9.1 Introduction to Europe Artificial Heart Markets in 2024
9.2 Europe Artificial Heart Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Artificial Heart Market Size Outlook by Segments, 2021-2030
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
10 Asia Pacific Artificial Heart Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Artificial Heart Markets in 2024
10.2 Asia Pacific Artificial Heart Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Artificial Heart Market size Outlook by Segments, 2021-2030
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
11 South America Artificial Heart Market Analysis and Outlook To 2030
11.1 Introduction to South America Artificial Heart Markets in 2024
11.2 South America Artificial Heart Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Artificial Heart Market size Outlook by Segments, 2021-2030
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
12 Middle East and Africa Artificial Heart Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Artificial Heart Markets in 2024
12.2 Middle East and Africa Artificial Heart Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Artificial Heart Market size Outlook by Segments, 2021-2030
By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Abiomed
Berlin Heart Inc
BiVACOR Inc
Calon Cardio-Technology Ltd
Carmat
CryoLife Inc
Jarvik Heart Inc
ReinHeart TAH GmbH
SynCardia Systems Llc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Ventricular Assist Device
Total Artificial Heart
Heart-Lung Machine
Others
By Power Source
Internal Battery
External Battery
By End-User
Hospitals and Clinics
Specialty Clinics